Ligand Form 144 details planned stock sale

Ligand common stockholder Jason Haas filed a Form 144 indicating an intent to sell common shares of LGND through Morgan Stanley Smith Barney LLC on or after August 12, 2026, with sales expected on NASDAQ.

Rhea-AI Filing Summary

Ligand common stockholder Jason Haas filed a Form 144 indicating an intent to sell common shares of LGND through Morgan Stanley Smith Barney LLC on or after August 12, 2026, with sales expected on NASDAQ. The securities to be sold were acquired from the issuer via stock option exercises dated August 12, 2026 for 2,759 and 3,379 common shares, and via restricted stock granted June 29, 2025 for 1,000 shares. The filing also reports that, in the prior three months, Haas sold 6,461 common shares on June 12, 2026 for aggregate consideration of 1651320.33.

Key Figures

Stock option shares (first tranche): 2,759 shares Stock option shares (second tranche): 3,379 shares Restricted stock grant: 1,000 shares +2 more

5 metrics

Stock option shares (first tranche) 2,759 shares Common stock acquired via stock option exercise dated August 12, 2026

Stock option shares (second tranche) 3,379 shares Common stock acquired via stock option exercise dated August 12, 2026

Restricted stock grant 1,000 shares Common stock acquired as restricted stock dated June 29, 2025

Shares sold in prior 3 months 6,461 shares Common stock sale on June 12, 2026 reported under past 3 months

Aggregate consideration for June 12, 2026 sale 1651320.33 Total consideration for 6,461 common shares sold on June 12, 2026

Key Terms

Form 144, Stock Option Exercise, Restricted Stock

3 terms

Form 144 regulatory

"Ligand common stockholder Jason Haas filed a Form 144 indicating an intent to sell"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 08/12/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock financial

"Common | 06/29/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

FAQ

What does LGND’s Form 144 filed by Jason Haas disclose?

It discloses that Jason Haas intends to sell common stock of LGND through Morgan Stanley Smith Barney LLC, with potential sales beginning on August 12, 2026 on NASDAQ, and lists how and when the shares were acquired.

How were the LGND shares in the Form 144 acquired by Jason Haas?

The shares were acquired from the issuer through stock option exercises on August 12, 2026 for 2,759 and 3,379 shares, and through a restricted stock award of 1,000 shares dated June 29, 2025.

What past LGND stock sale is reported for Jason Haas in this Form 144?

The filing reports that on June 12, 2026, Jason Haas sold 6,461 LGND common shares for aggregate consideration of 1651320.33, which is disclosed under securities sold during the past three months.

Which broker is listed for the planned LGND stock sale in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, and the planned sales are expected to occur on NASDAQ.

Does the LGND Form 144 specify when Jason Haas may begin selling shares?

Yes. The filing lists an approximate sale date of August 12, 2026 for the LGND common shares, indicating when sales under this Form 144 may commence, typically subject to applicable volume and timing limitations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:24 PM Accepted by SEC EDGAR 08/12/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001883821
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LIGAND PHARMACEUTICALS INCORPORATED
SEC File Number	001-33093
Address of Issuer	555 Heritage Drive, Suite 200 Jupiter FLORIDA 33458
Phone	(858) 550-7500
Name of Person for Whose Account the Securities are To Be Sold	Jason Haas
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7138	2090061.99	19935609	08/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2026	Stock Option Exercise	Issuer			2759	08/12/2026	Cash
Common	08/12/2026	Stock Option Exercise	Issuer			3379	08/12/2026	Cash
Common	06/29/2025	Restricted Stock	Issuer			1000	06/29/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JASON HAAS 555 Heritage Drive, Suite 200 Jupiter FL 33458	Common	06/12/2026	6461	1651320.33

144: Remarks and Signature

Remarks
Date of Notice	08/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jason Haas
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)